Muhlenkamp White Paper: Transforming the Face of Medicine

Muhlenkamp White Paper: Transforming the Face of Medicine

Tammy S. Neff joined Muhlenkamp & Company, Inc. in September 2003.
Her responsibilities are primarily research oriented, including evaluating company fi nancial statements, annual reports, and proxy statements; analyzing industry and company research reports; interviewing and visiting company management teams; and making investment recommendations for inclusion in the Muhlenkamp portfolios.


Transforming the Face of Medicine:
Advances in Biomedical Science
Advances in biomedical science are transforming the way healthcare is being provided. This booklet examines some breakthrough innovations, along with a look at some of the companies making these advancements. Areas of interest include:
• Personalized medicine;
• Cancer and targeted cancer therapies;
• Immune system;
• Viruses; and
• 3-D bioprinting.
Personalized Medicine
Personalized medicine is the application of information learned from studying the human proteome. Scientifi c discoveries in the lab continue to make their way into clinical practice, ushering in a new era of medicine. Arriving at this point requires some background.

Long Thesis For Exro Technologies

Exro Electrified Mobility 2There's been a mad dash to find the next Tesla in recent years, with billions of dollars being poured into electric vehicle companies. Components have received less attention than complete vehicles, but one ValueWalk subscriber found a component maker he believes would be a good investment. During a recent webinar, subscriber David Schneider shared his Read More

[pdfjs-viewer url= viewer_width=700px viewer_height=800px fullscreen=true print=true download=true openfile=false]


Updated on

No posts to display